The pharmaceutical and biotechnology industry continues to experience massive change driven by external and internal factors that, combined, present opportunities for deep reflection and essential transformation.
-
External demographic and economic pressures include an aging global population, rising chronic disease, changing customer expectations and increasing regulatory scrutiny.
-
Internal Research & Development (R&D) organizations are considering important imperatives to help drive future success:
-
Pivot to the patient—transforming R&D models to be more patient outcome focused
-
Advance to the next generation of R&D operating models—facilitating cost reductions to improve productivity
-
Drive scientific and operational excellence—advancing faster time to market from first-in-human to approval
Comment submitted
Submitted comment may not display automatically.